Evidence map›Paper›PMID 40815909›Full record

ArticleDrug and alcohol dependence2025

Oral microbial profiles in young adults with cannabis use disorder.

Brittney D Browning, Rachel L Tomko, Anna E Kirkland, Rachel Visontay, Pamela L Ferguson, Alexander V Alekseyenko, Melinda A Engevik, Louise Mewton, Lindsay M Squeglia

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brittney D BrowningDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA. Electronic address: brownibr@musc.edu.
Rachel L TomkoDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
Anna E KirklandDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Rachel VisontayThe Matilda Centre for Research in Mental Health and Substance Use, University of Syndey, Sydney, Australia.
Pamela L FergusonDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Alexander V AlekseyenkoDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Melinda A EngevikDepartment of Regenerative Medicine, Medical University of South Carolina, Charleston, SC, USA.
Louise MewtonThe Matilda Centre for Research in Mental Health and Substance Use, University of Syndey, Sydney, Australia.
Lindsay M SquegliaDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
DRUG ABUSE TRAINING PROGRAMT32DA007288 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Christopher W Cowan, Rachel Penrod-Martin · 1991 to 2026
$11.8M
Mentoring Clinical Investigators in Patient-Oriented Adolescent Alcohol ResearchK24AA031052 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Lindsay Squeglia · 2024 to 2026
$644k
The effects of adolescent alcohol use on oral microbiota and the brainK01AA031745 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Anna E Kirkland · 2024 to 2026
$583k
NCATS NIH HHS UL1 TR001450NIAAA NIH HHS K01 AA031745NIAAA NIH HHS K24 AA031052NIDA NIH HHS T32 DA007288
6 · The paper itself

Abstract

backgroundWith increasing legalization and rising potency of cannabis products, cannabis use disorder (CUD) is a growing public health concern, particularly among young adults, who have the highest rates of CUD. While substance use is known to be associated with the oral microbiome, the impact of CUD remains understudied. Given the oral microbiome's role in overall health, identifying microbial signatures associated with CUD, relative to other substance use disorders (SUDs), may provide insight into its biological mechanisms and potential therapeutic targets.

methodsSaliva samples were collected from young adults (ages 18-25; N = 192) with CUD (n = 129) and non-CUD SUD (n = 63). The non-CUD SUD control group allowed for isolation of CUD-related associations in a population that often uses multiple substances. Using 16S rRNA gene sequencing, we examined alpha diversity, beta diversity, and taxa abundance between the groups and in relation to cannabis use patterns (frequency and amount; CUD group only), controlling for sequencing batch, age, sex, race, body mass index (BMI), and alcohol use.

resultsCompared to the non-CUD SUD group, the CUD group exhibited significantly lower alpha diversity, distinct beta diversity, and differences in taxa abundance. Among those with CUD, greater cannabis use frequency was linked to lower diversity, while both frequency and amount were associated with higher abundances of strict anaerobes.

conclusionsCUD is associated with specific alterations in the oral microbiome, including lower diversity and taxonomic shifts. Associations with cannabis use patterns underscore the relevance of frequent and heavy use. Future research should explore the functional implications of these findings for CUD-related outcomes.

Indexed as

Marijuana AbuseMicrobiotaMouthSalivaAdolescentAdultFemaleHumansMaleRNA, Ribosomal, 16SYoung AdultRNA, Ribosomal, 16SCannabisMicrobiomeSubstance useYoung adult

Identifiers

PMID40815909
PMCPMC13098379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.